← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2006Last known activity
Sep 30, 2022
Timeline
1910s
- Jun 23, 1911
Mars, Inc.— Founded
Drugs by trial phase (17 distinct, 17 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (13 own, 0 via acquisition)
Indications
Studied for
Recent trials (26)
- NCT06294938Lead sponsorN/ASep 30, 2022
- NCT03587883Study directorN/AMar 23, 2018
- NCT03587883CollaboratorN/AMar 23, 2018
- NCT03526107Study directorN/AFeb 16, 2017
- NCT03526107CollaboratorN/AFeb 16, 2017
- NCT03526107Overall official - principal investigatorN/AFeb 16, 2017
- NCT03194620Study directorN/AAug 31, 2016
- NCT03194620CollaboratorN/AAug 31, 2016
- NCT04582617CollaboratorPhase 4Aug 26, 2016
- NCT03526094Study directorN/AMay 5, 2016
- NCT03526094CollaboratorN/AMay 5, 2016
- NCT03030053CollaboratorN/AFeb 1, 2016
- NCT02312310CollaboratorN/ADec 1, 2015
- NCT02422745CollaboratorPhase 4Jun 1, 2015
- NCT03526081Study directorN/AJan 20, 2015
Details
- Founded
- Chicago, IL, US Jun 23, 1911
- Last known activity
- Sep 30, 2022